Objective:

To examine the inequities in access to care for inflammatory bowel disease (IBD) and propose strategies to improve equity in treatment and outcomes, particularly by addressing social determinants of health.

Key Findings:

• The global burden of IBD is increasing, particularly in LMICs and rural areas, with specific statistics on incidence rates.
• Access to high-quality care is uneven, with significant disparities based on geography, socioeconomic status, and ethnicity, supported by data.
• Structural factors like healthcare workforce shortages and fragmented care worsen inequities, with examples.
• Equitable care requires addressing social determinants of health and enhancing patient-centered approaches, highlighting the urgency of action.

Interpretation:

Achieving equitable access to IBD care is crucial for improving health outcomes and quality of life for affected populations, necessitating coordinated efforts across various sectors and emphasizing the implications of these efforts.

Limitations:

• The article may not cover all regional variations in IBD care access, particularly in underrepresented areas.
• Limited data on the effectiveness of proposed strategies in diverse settings, highlighting the need for further research.

Conclusion:

Coordinated action among clinicians, policy-makers, patients, and industry is essential to ensure sustainable, patient-centered, and inclusive IBD care globally, underscoring the urgency of addressing these disparities.